๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Myeloablative therapy for primary resistant multiple myeloma

โœ Scribed by Raymond Alexanian; Meletios A. Dimopoulos; Kay B. Delasalle; Jeane Hester; Richard Champlin

Book ID
112212770
Publisher
AlphaMed Press
Year
1996
Tongue
English
Weight
306 KB
Volume
13
Category
Article
ISSN
1066-5099

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Thalidomideโ€“dexamethasone as primary the
Thalidomideโ€“dexamethasone as primary therapy for advanced multiple myeloma
โœ Michael Wang; Donna M. Weber; Kay Delasalle; Raymond Alexanian ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 59 KB ๐Ÿ‘ 1 views

## Abstract The value of thalidomideโ€“dexamethasone was assessed in 26 consecutive, previously untreated patients with multiple myeloma of high tumor mass. All showed Hgb < 8.5 g/dL, serum calcium > 11.5 mg/dL, or both. The response rate was 73%, frequency of early death < 3 months was 5%, projected